Abbott Wins 'Sorvir' Trademark Dispute In EU Court

Law360, New York (September 13, 2010, 7:11 PM EDT) -- Overturning a ruling by the European Union's trademark office, an EU court ruled Monday that the “Sorvir” trademark requested by Japanese pharmaceutical company aRigen Inc. was too similar to the “Norvir” mark already held by Abbott Laboratories.

The General Court of the Court of Justice of the European Union decided that although the marks were essentially made up and devoid of any particular meaning, the signs' phonetic and visual similarity created a likelihood that the general public would think the two products were related.

“While the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.